Back to drug

The Drug-Induced Respiratory Disease Website

Publications

Eto M, Uemura H, Tomita Y, Kanayama H, Shinohara N, Kamei Y, Fujii Y, Umeyama Y, Ozono S, Naito S, Akaza H,

Overall survival and final efficacy and safety results from a Japanese phase II study of axitinib in cytokine-refractory metastatic renal cell carcinoma.

Cancer science 2014 Dec;105;1576-83 — 2014 Dec — 1576-83